Skip to main content

and
  1. No Access

    Article

    Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy

    We examined risk of second cancer and late mortality in a population-based Australian cohort of 717 pediatric allogeneic stem cell transplant (HSCT) recipients treated for a malignant disease during 1982–2007....

    A S Nelson, L J Ashton, C M Vajdic, R E Le Marsney, B Daniels, I Nivison-Smith in Leukemia (2015)

  2. No Access

    Article

    Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study

    Population-based evidence on second cancer risk following autologous haematopoietic SCT (HCT) is lacking. We quantified second cancer risk for a national, population-based cohort of adult Australians receiving...

    I A Bilmon, L J Ashton, R E Le Marsney, A J Dodds in Bone Marrow Transplantation (2014)

  3. No Access

    Chapter and Conference Paper

    Plasma Exchange

    Plasma exchange has been used as a therapeutic tool since the beginning of the century (Abel et al., 1914). However its use has increased markedly since the development of efficient machines to perform the man...

    A. J. Dodds in Clinical Aspects of Blood Viscosity and Cell Deformability (1981)